Analytical Data
-
基因名
NUAK1
- Application
-
种属
Human
-
表达系统
Baculovirus
-
标签
GST
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O60285-1
-
表达区间
E2-N661
-
蛋白长度
Full Length of Isoform-1
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
NUAK1 (Nuclear-Akt interacting protein 1) is a serine/threonine kinase that plays a crucial role in various cellular processes, including metabolism, cell proliferation, and cytoskeletal dynamics. As a member of the AMP-activated protein kinase (AMPK) family, NUAK1 is activated under energy-depleted conditions and contributes to cellular adaptation to stress. Aberrant NUAK1 expression has been linked to numerous cancers and metabolic disorders, making it a potential therapeutic target. Research into NUAK1 recombinant proteins has gained momentum as scientists strive to elucidate its function and regulatory mechanisms within the cellular context. By studying NUAK1's interaction with other proteins and its influence on signaling pathways, researchers hope to uncover its role in disease progression and identify novel strategies for intervention. The development of recombinant NUAK1 proteins is essential for in vitro studies, as it allows for detailed biochemical and biophysical characterization, offering insights into its enzymatic activity and substrate specificity. Understanding NUAK1's function in health and disease can pave the way for innovative therapeutic approaches aimed at modulating its activity, thereby providing potential benefits in cancer treatment and metabolic disorder management.
